2027 will put more pressure on every major book of business. Aggregate reporting will tell you what happened. Provider level intelligence can show you where MLR, quality, efficiency, and provider performance are moving while there’s still time to act.

There’s a provider group in your network running a few points above trend right now.

It isn’t your largest group, and it isn’t in your worst contract. That’s exactly why nobody has raised it.

That same group may be contributing disproportionately to MLR. Its quality measures may be moving toward a threshold that determines whether you collect a bonus or withhold. Its documentation may be thin enough that legitimate clinical risk your members carry isn’t fully reflected in current risk scores. Its utilization patterns may also be pointing to an efficiency problem that disappears when performance is rolled up.

And it may sit in a market where you’ll eventually need to prove provider performance to defend a contract, negotiate a renewal, or win the next piece of business.

Four financial problems. One provider group.

Yet in many health plans, those signals are being picked up in separate reports, by separate teams, at different points in time. Medical economics may flag the MLR or cost variance while Quality tracks the measure gaps. Risk adjustment sees a documentation opportunity, and Network is looking at provider performance through the lens of the contract and its next renewal.

Each team can be right. Each report can be accurate. And leadership can still be left without the answer that matters most:

Where should we intervene first?

The problem isn’t that every TIN deserves the same level of attention. It’s that most organizations don’t have a common view of which provider groups are having the greatest effect on the financial result right now.

Most plans already have the data. What they often lack is the ability to connect those signals at the level and speed required to act.

By the time the numbers reach leadership, they may already be rolled up above the level where decisions get made, fragmented across functions, or arriving after part of the window to influence the outcome has closed.

Why the move into 2027 makes that gap more expensive

Health plans have managed difficult trend years before. What makes the approach to 2027 different is the number of pressures converging across major books of business at the same time.

Commercial medical cost trend remains elevated. Individual market populations are shifting. Medicaid enrollment and attribution may change as new requirements take effect. Medicare Advantage plans are already operating under full V28 while facing greater audit scrutiny and a tougher quality environment.

Different books. Different pressures. But they create the same leadership challenge:

Historical aggregates become less useful as a predictor of what happens next precisely when the cost of missing an emerging signal goes up.

Health plan leaders are being asked to protect margin, improve quality, find new efficiency, and get more from provider relationships at the same time.

The answer isn’t another report.

It’s knowing which provider groups are moving now, what’s driving the movement, what’s financially at stake, and whether there’s still enough time to change the result.

As plans prepare for 2027, the advantage will increasingly belong to organizations that can turn a signal into a decision faster.

Three places the money sits

1. Money leaking where no contract triggers a review

Aggregate MLR is a symptom. Nobody manages an aggregate.

A plan may review its value based portfolio and see strong overall performance. Contracts are working, participation is healthy, and the results appear favorable.

But the roll up can hide very different performance underneath. Strong and weak TINs average into one comfortable number, while some of the largest cost and efficiency opportunities may never enter the review at all.

Think about non VBC groups, PCMH populations, and unattributed spend.

Without a settlement cycle, JOC, or contract milestone, there may be no built in reason to ask whether those provider groups are contributing disproportionately to MLR or whether utilization and efficiency are beginning to deteriorate.

We worked with a plan covering roughly 800,000 commercial and Medicare Advantage lives whose value based program was genuinely producing results. Approximately $50 million had already been realized.

Then we looked outside the portion of the network receiving the most attention.

Roughly $90 million in additional exposure was sitting in non VBC and PCMH groups that had never been quantified.

The largest financial exposure wasn’t in the contracts performing worst.

It was in the part of the network receiving the least attention.

Not because the data didn’t exist, but because nothing in those arrangements created a reason to look.

You can’t improve MLR or manage provider performance across a network you can only see in aggregate.

2. Money the organization may have earned but could still lose

Not every financial opportunity comes from reducing medical cost. Some of it is revenue the organization has already done much of the work to earn but could still lose because the opportunity was identified too late.

Quality is one example.

For 2026, the number of Medicare Advantage contracts earning at least four stars declined, as did the percentage of MA enrollment in bonus qualifying plans.

The significance isn’t the national average. It’s what happens financially when relatively small movement at the measure level determines whether an individual contract clears a bonus or withhold threshold.

You can’t manage the cut point. You can manage your position against it while there’s still time to influence performance.

That means knowing more than the measure score. You need to know which provider groups and member populations are driving it and where intervention still has enough runway to matter.

Risk adjustment creates a similar timing problem. Under V28, the objective isn’t maximum capture. It’s accurate, defensible capture of the conditions that legitimately belong in the model.

That requires knowing where documentation gaps are emerging, which members are affected, and which providers are associated with them while action can still be taken.

If quality and risk opportunities are discovered primarily during retrospective review, the organization may understand exactly what happened after much of its ability to change the result has disappeared.

Too often, the problem isn’t effort. It’s time.

3. Money that depends on your ability to prove performance

Some provider performance gaps cost you money inside the contract.

Others can cost you the next contract.

Some of the largest financial decisions happen during procurements, renewals, negotiations, and competitive bids.

Incumbent status helps. Relationships help. A strong proposal helps. But there’s a meaningful difference between describing what your organization plans to do and proving what’s already operating.

We watched that distinction help settle an award.

A plan bid into a state where it had no existing presence, competing against organizations with established provider relationships. It won a contract representing roughly 400,000 members and approximately $2 billion in annual premium.

It didn’t simply promise a stronger value based program. It could demonstrate one.

Arrangements could be administered in one place. Settlement could run on cycle. Analytics could be configured to the state’s requirements. Provider performance could be surfaced and acted on rather than described as a future capability.

The same principle applies to employer renewals, health system negotiations, provider contracting, and competitive RFPs.

When someone asks whether your organization can manage MLR, improve quality, drive efficiency, or change provider performance, proof carries more weight than a roadmap.

Whatever you plan to claim at your next negotiation should already be visible in your current operations.

The interval is the whole problem

Catch a trend in month one and you still have most of a performance year to work with. Catch it in month six and real money has already moved. Catch it in month eight and much of the outcome may already be locked.

That interval is where a surprising amount of financial performance gets decided.

When visibility arrives late, the response is familiar: stand up a task force, bring in a consultant, schedule another steering committee, and spend another quarter determining what happened.

None of those activities are inherently wrong. They’re expensive substitutes for seeing the signal earlier.

That’s the real difference between reporting and prospective intelligence.

From retro-reporting to prospective intelligence

Closing the gap doesn’t require leadership to monitor every provider, measure, member, and contract individually. It requires being able to connect them when something moves.

You need a reliable view of what was contracted and what it paid. You need performance resolved to the level where someone can actually act: contract, group, TIN, measure, member cohort, and cost driver.

And you need prospective signals that surface what changed, why it matters financially, and where intervention is still possible.

A dashboard telling you MLR increased is reporting.

Knowing which provider groups are driving the movement, what’s causing it, what it may cost, and where your team can still intervene is intelligence.

The plans best positioned to protect margin and market position next year won’t necessarily be the ones entering 2027 with the most reporting. They’ll be the ones entering it with a clearer view across MLR, Quality, Efficiency, and Provider Performance, and the ability to trace those results back to the providers, members, measures, contracts, and decisions producing them while there’s still enough time to change the outcome.

Start with one book of business.

We’ll help you look across MLR, Quality, Efficiency, risk, and Provider Performance to uncover where the signals are pointing, where visibility may be breaking down, and where deeper analysis could reveal meaningful opportunity.

In our experience, the biggest number is often somewhere the existing reporting cycle was never designed to look.